JANX filings
Corporate insider profile
Janeen Noel Doyle Filing Activity
Latest reported as Chief Corp. & Bus. Dev. Ofcr of Janux Therapeutics, Inc. (JANX).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$56,943.71
- Latest transaction
- Jun 2, 2026
Affiliated corporations
Reported company relationships
Transaction history
